The largest database of trusted experimental protocols

Percp conjugated cd34

Manufactured by BD
Sourced in Germany

PerCP-conjugated CD34 is a fluorescently labeled antibody that binds to the CD34 antigen. CD34 is a cell surface glycoprotein expressed on hematopoietic stem and progenitor cells. The PerCP fluorescent dye is used to label the CD34 antibody, allowing for the detection and identification of CD34-positive cells in flow cytometry applications.

Automatically generated - may contain errors

4 protocols using percp conjugated cd34

1

Quantifying Cell-Surface Antigens by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
The expression of cell-surface antigens was quantified by immunostaining as described previously [7 (link)]. We used the following monoclonal antibodies (anti-human): PE-conjugated CD133 (Miltenyi Biotec, Bergisch-Gladbach, Germany), PerCP-conjugated CD34 (BD Biosciences, Heidelberg, Germany), and either FITC-conjugated CXCR-4 or APC-conjugated c-Kit, APC-conjugated CXCR-2 (all R&D Systems, Wiesbaden-Nordenstadt, Germany), PE-conjugated PSGL1 (BD Biosciences, Heidelberg, Germany) or the indirect rabbit anti-human polyclonal RAGE antibody (Biozol, Eching, Germany), for which a FITC-conjugated anti-rabbit IgG antibody (Invitrogen, Karlsruhe, Germany) was used. We used a FACSCalibur flow cytometer (BD Biosciences) for flow cytometry. FACS-data analysis was performed with WinMDI 2.8 software (Scripps Research Institute, La Jolla, CA). EPC counts are expressed as percentage referred to total PMBC in each study subject.
+ Open protocol
+ Expand
2

Identification of Endothelial Progenitor and Circulating Endothelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were collected from freshly placed venous cannulas. Fifty microliters of
blood sample were incubated with 5 µL of FITC-labeled CD144 (BD Biosciences),
PE-conjugated CD133 (AC133; Miltenyi Biotec GmbH, Bergisch Gladbach, Germany),
Per-CP-conjugated CD34 (BD Biosciences), and APC-conjugated CD45 (BD Biosciences) for 20
minutes. After incubation, RBC lysis and washing were done and the cells were suspended
in PBS, and FACSCalibur flow cytometric analysis was done with Cell Quest software (BD
Biosciences). Antihuman IgG was used as an isotype negative control and 50 000 events
were analyzed. The EPCs are negative for CD45, positive for CD144, CD34, and CD133
(CD45 CD34+ CD144+ CD133+), while CECs
are negative for CD45, positive for CD144 and CD34 and negative for CD133
(CD45 CD34+ CD144+ CD133). The CECs and
EPCs were expressed as absolute count per 50 000 cells (Figure 2).
+ Open protocol
+ Expand
3

Quantification of Circulating and Endothelial Progenitor Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole blood samples from patients were processed within 2 h of collection. Samples were assessed by flow cytometry on an LSR II (BD Biosciences, San Jose, CA) using the following antibodies: Allophycocyanin-conjugated CD133 (Miltenyi Biotec, Auburn, CA), PerCP-conjugated CD34 (BD Biosciences), and PE-conjugated VEGFR2 (R&D Systems, Emeryville, CA). Data were analyzed with FlowJo software (Tree Star, Ashland, OR). Patient samples were performed in triplicate; the mean of three runs was used as CPC and EPC levels. To assess interassay variability, five samples from one patient were drawn on five separate days and analyzed with consistent results (<5% variation). CPCs were quantified as cells positive for CD34 and CD133 markers. EPCs were quantified as cells positive for CD34, CD133, and VEGFR2 markers.
+ Open protocol
+ Expand
4

FACS Analysis of PBMC Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood mononuclear cells (PBMC) were isolated by Ficoll gradient centrifugation (Amersham Biosciences, Freiburg, Germany). Cell-surface antigens expression was quantified by Fluorescence Activated Cell Sorting (FACS) analysis as described previously [8 (link)]. The following anti-human monoclonal antibodies have been used: PE-conjugated CD133 (Miltenyi Biotec, Bergisch-Gladbach, Germany), PerCP-conjugated CD34 (BD Biosciences, Heidelberg, Germany), and either FITC-conjugated VCAM-1/CD106, FITC-conjugated ICAM-1/CD54, FITC-conjugated E-selectin/CD62E and FITC-conjugated L-selectin/CD62L. Flow cytometry was executed on a FACSCalibur flow cytometer (BD Biosciences) and data analysis was performed using WinMDI 2·8 software (Scripps Research Institute, La Jolla, CA). CD34+/CD133+-stem cell counts are expressed as percentage of total PBMC in each patient or control.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!